Literature DB >> 369834

delta-9-Tetrahydrocannabinol suppression of episodic luteinizing hormone secretion in the ovariectomized rat.

L Tyrey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 369834     DOI: 10.1210/endo-102-6-1808

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  8 in total

Review 1.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

2.  Effects of prenatal exposure to delta-9-tetrahydrocannabinol on reproductive, endocrine and immune parameters of male and female rat offspring.

Authors:  L L Murphy; J Gher; A Szary
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

3.  Regulation of gonadotropin-releasing hormone secretion by cannabinoids.

Authors:  C Michael Gammon; G Mark Freeman; Weihua Xie; Wihua Xie; Sandra L Petersen; William C Wetsel
Journal:  Endocrinology       Date:  2005-07-14       Impact factor: 4.736

Review 4.  Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes.

Authors:  Jamie O Lo; Jason C Hedges; Guillermina Girardi
Journal:  Am J Obstet Gynecol       Date:  2022-05-31       Impact factor: 10.693

5.  The effect of delta 1tetrahydrocannabinol on luteinizing hormone release in castrated and hypothalamic deafferented male rats.

Authors:  M Puder; I Nir; R A Siegel; J Weidenfeld; D Ayalon
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

6.  Pituitary function following treatment with reproductive toxins.

Authors:  R L Cooper; J M Goldman; G L Rehnberg
Journal:  Environ Health Perspect       Date:  1986-12       Impact factor: 9.031

7.  Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons.

Authors:  Imre Farkas; Imre Kalló; Levente Deli; Barbara Vida; Erik Hrabovszky; Csaba Fekete; Suzanne M Moenter; Masahiko Watanabe; Zsolt Liposits
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

8.  Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives.

Authors:  Sari G Ferber; Reut Hazani; Gal Shoval; Aron Weller
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.